TL;DR
This paper expands the genome editing toolbox by identifying and characterizing 16 new Cpf1 orthologs for use in eukaryotic cells. Notably, they found that Moraxella bovoculi AAX11_00205 (Mb3Cpf1) exhibits robust activity and a more relaxed PAM recognition than previously known Cpf1 enzymes, opening up new possibilities for targeted gene editing.
What Problem Does This Paper Address?
CRISPR-Cas systems have revolutionized genome engineering, with Cas9 being the most widely used. However, the Cpf1 endonuclease, a class 2 CRISPR system, offers distinct advantages such as processing its own guide RNA array and requiring only a single RNA guide. These features make Cpf1 particularly attractive for applications like multiplexed gene editing and targeting AT-rich regions. Despite its promise, the repertoire of active Cpf1 orthologs in eukaryotic systems was limited. This paper addresses the need to expand this repertoire by systematically screening and evaluating a larger set of Cpf1 orthologs for their nuclease activity in human cells, aiming to discover new enzymes with potentially improved or distinct properties.
Methods
The researchers employed a multi-pronged approach:
- Bioinformatic Selection: They computationally searched for Cpf1 orthologs, selecting 16 candidates based on homology to previously characterized active Cpf1 enzymes.
- In Vitro PAM Identification: An in vitro assay was used to determine the Protospacer Adjacent Motif (PAM) sequences recognized by each Cpf1 ortholog. This involved incubating Cpf1 nucleases with a library of DNA targets containing randomized PAM sequences and identifying which PAMs were cleaved.
- Eukaryotic Cell Activity Assays:
- HEK293T Cell Transfection: Human codon-optimized Cpf1 orthologs and their corresponding guide RNAs (crRNAs) were expressed in HEK293T cells.
- Indel Detection: The Surveyor nuclease assay was used to detect insertion/deletion (indel) events at targeted genomic loci, indicating nuclease activity.
- Deep Sequencing: For more detailed analysis, deep sequencing was employed to quantify indel frequencies at target sites.
- PAM Specificity Testing: For promising candidates, further experiments were conducted to assess their activity with different PAM sequences, including relaxed or non-canonical ones.
Datasets
Not discussed in the paper. The study primarily relies on in vitro assays and experiments conducted in cultured human cells (HEK293T).
Key Insights and Ideas
- Expanding the Cpf1 Toolbox: The study successfully identified four new Cpf1 orthologs that exhibit activity in human cells, significantly broadening the available options for Cpf1-mediated genome editing.
- Mb3Cpf1: A Promising New Enzyme: Moraxella bovoculi AAX11_00205 (Mb3Cpf1) emerged as a standout, demonstrating robust indel formation comparable to established Cpf1 enzymes like AsCpf1 and LbCpf1.
- Relaxed PAM Recognition: A key finding is that Mb3Cpf1 shows tolerance for a shortened PAM sequence (TTN) in addition to the canonical TTTV PAM. This flexibility in PAM recognition is highly valuable, as it can increase the number of potential target sites within a genome.
- Ortholog-Specific Activity: The research highlights that different Cpf1 orthologs can have varying PAM specificities and activity levels, underscoring the importance of screening diverse orthologs for specific applications.
- Conserved crRNA Maturation: The high homology observed in the stem structure and AAUU motif of Cpf1 direct repeats suggests a conserved mechanism for crRNA maturation across the Cpf1 family.
Key Results
- Four active orthologs identified: Thiomicrospira sp. Xs5 (TsCpf1), Moraxella bovoculi AAX08_00205 (Mb2Cpf1), Moraxella bovoculi AAX11_00205 (Mb3Cpf1), and Butyrivibrio sp. NC3005 (BsCpf1) showed detectable indel events in human cells.
- Mb3Cpf1's robust activity: Mb3Cpf1 achieved indel frequencies of >20% with multiple guides and showed activity comparable to AsCpf1 and LbCpf1.
- Mb3Cpf1's relaxed PAM: Mb3Cpf1 demonstrated activity at TTN PAMs, albeit with lower efficiency than at TTTV PAMs. It also showed activity at RTTV PAMs.
- Comparison of activity: At TTTV PAMs, Mb3Cpf1 showed an average activity of ~18%, while AsCpf1 was ~28% and LbCpf1 was ~13%. At NTTN PAMs, Mb3Cpf1 had an average activity of ~5.3%, compared to ~2.7% for AsCpf1 and ~1.4% for LbCpf1.
Limitations and Future Work
- Organism-Specific Activity: The authors note that Cpf1 ortholog activity can be organism-dependent, citing a previous study showing weak FnCpf1 activity in mammalian cells but robust activity in plant cells. This suggests that further validation in various organisms may be necessary.
- Further PAM Exploration: While Mb3Cpf1's relaxed PAM recognition was explored, there's potential for deeper investigation into its full PAM tolerance and the precise rules governing its recognition.
- Optimization for Specific Applications: The newly identified orthologs, particularly Mb3Cpf1, could be further engineered or optimized for specific genome editing applications, potentially enhancing their efficiency or specificity.
- Multiplexing Potential: The paper mentions Cpf1's utility in multiplexed gene targeting. Future work could explore the multiplexing capabilities of these newly characterized orthologs.
Summary updated